B
RPTP

Bailard’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bailard’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,000
Closed -$269K – 353
2016
Q2 		$269K Hold
50,000
– – 0.03% 255
2016
Q1 		$230K Buy
+50,000
New +$201K 0.03% 229
2015
Q4 		– Sell
-145,000
Closed -$877K – 404
2015
Q3 		$877K Sell
145,000
-15,000
-9% -$184K 0.14% 103
2015
Q2 		$2.53M Buy
+160,000
New +$1.94M 0.39% 44

Other funds holding RPTP

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Bailard's RPTP Position: Q3 2016 in Review

Bailard sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 50,000 shares — an estimated $269K sold.

Bailard first reported a position in RPTP in Q2 2015 and held it in 4 quarters. The position peaked at $2.53M in Q2 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Bailard reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Bailard sold 50,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $269K.
  • Bailard first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 4 quarters.
  • Bailard's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.53M in Q2 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Bailard's 13F filing for Q3 2016, filed 9 Nov 2016.